4th Diabetes Partnering and Deal-Making Conference
Conference - Cambridge, MA, United States
With more than 400 drug candidates for diabetes in active development and in light of the recent US Food and Drug Administration (FDA) guidance to assess cardiovascular risk in clinical trials, the burden to develop novel drugs is greater and the barrier for success has become higher than ever. What will be the next block-buster drug target for T1DM and T2DM? How does the recent FDA guidance affect our approach to develop new medications for diabetes? How do different size companies adapt the best strategy to be competitive in this field?
GTC’s 4th Diabetes Partnering and Deal-Making Conference part of the Diabetes Summit 2014 scheduled for April 23-25, 2014 in Cambridge, MA, is a partnering and business development conference that gives companies an opportunity to network with high-level executives and explore potential collaborations, learn about relevant issues and deals that will affect the industry. The conference will bring together the leading experts on diabetes from both industry and academia to discuss business strategies and opportunities under the current regulatory landscape.
Organization: GTC
(Courtesy of 4th Diabetes Partnering and Deal-Making Conference logo, via allcongress.com)
4th Diabetes Partnering and Deal-Making Conference (April 23 - 25, 2014, Cambridge, MA)
Wed, Apr 23, 2014 - Fri, Apr 25, 2014
Hyatt Regency Cambridge
575 Memorial Drive Cambridge, MA 02139
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
